Title : Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.

Pub. Date : 2003 Dec

PMID : 14703068






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer. Epirubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer. Epirubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens
3 Since neoadjuvant chemotherapy with epirubicin and docetaxel is increasingly used in advanced breast cancer, our purpose was to assess the influence of this neoadjuvant chemotherapy on the expression of the growth factor receptor HER2/neu. Epirubicin erb-b2 receptor tyrosine kinase 2 Homo sapiens